检测方案
98%
形式
solid
bp
170 °C/12 mmHg (lit.)
mp
39-42 °C (lit.)
SMILES字符串
Clc1ccc(CC#N)cc1Cl
InChI
1S/C8H5Cl2N/c9-7-2-1-6(3-4-11)5-8(7)10/h1-2,5H,3H2
InChI key
QWZNCAFWRZZJMA-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
应用
3,4-Dichlorophenylacetonitrile was used in the synthesis of:
- SR 48968, a potent, competitive and selective non-peptide antagonist of the neurokinin A (NK2) receptor
- tachykinin NK3 receptor antagonist SR 142801, (R)-N-[ 1-[3-[ 1-benzoyl-3-(3,4-dichlororphenyl)-3-piperidinyl]propyyl]-4-phenyl-4-piperidinyl-N-methyl acetamide
- MDL 105,212, a non-peptide tachykinin receptor antagonist
警示用语：
Warning
危险分类
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
WGK
WGK 3
闪点(°F)
235.4 °F
闪点(°C)
113 °C
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
Pharmacological profile and chemical synthesis of SR 48968, a non-peptide antagonist of the neurokinin A (NK2) receptor.
Emonds-Alt X, et al.
Bioorganic & Medicinal Chemistry Letters, 3(5), 925-930 (1993)
A practical and scalable synthesis of SR 142801, a tachykinin NK3 antagonist.
Chen HG, et al.
Bioorganic & Medicinal Chemistry Letters, 7(5), 555-560 (1997)
Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK1and NK2 receptors.
Burkholder TP, et al.
Bioorganic & Medicinal Chemistry Letters, 6(8), 951-956 (1996)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门